Literature DB >> 19589842

The diagnosis of diabetes is changing: how implementation of hemoglobin A1c will impact clinical laboratories.

David B Sacks1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19589842     DOI： 10.1373/clinchem.2009.132704

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  7 in total

1.  Effects of hemoglobin variants on hemoglobin a1c values measured using a high-performance liquid chromatography method.

Authors:  Mercedes Lorenzo-Medina; Silvia De-La-Iglesia; Paloma Ropero; Patricia Nogueira-Salgueiro; Jesus Santana-Benitez
Journal:  J Diabetes Sci Technol       Date:  2014-06-22

2.  Development of affinity microcolumns for drug-protein binding studies in personalized medicine: interactions of sulfonylurea drugs with in vivo glycated human serum albumin.

Authors:  Jeanethe Anguizola; K S Joseph; Omar S Barnaby; Ryan Matsuda; Guadalupe Alvarado; William Clarke; Ronald L Cerny; David S Hage
Journal:  Anal Chem       Date:  2013-04-17       Impact factor: 6.986

Review 3.  HbA1c for screening and diagnosis of diabetes mellitus.

Authors:  Trefor Higgins
Journal:  Endocrine       Date:  2012-08-21       Impact factor: 3.633

4.  HbA1c of 6.5% to diagnose diabetes mellitus -- does it work for us? -- the Bellville South Africa study.

Authors:  Annalise E Zemlin; Tandi E Matsha; Mogamat S Hassan; Rajiv T Erasmus
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

5.  Letter: higher glycated hemoglobin level is associated with increased risk of ischemic stroke in non-diabetic korean male adults (diabetes metab j 2011;35:551-7).

Authors:  Seok Hong Lee; Jihyun Ahn; Jaetaek Kim
Journal:  Diabetes Metab J       Date:  2012-02-17       Impact factor: 5.376

6.  Glycated hemoglobin level is significantly associated with the severity of coronary artery disease in non-diabetic adults.

Authors:  Anping Cai; Guang Li; Jiyan Chen; Xida Li; Xuebiao Wei; Liwen Li; Yingling Zhou
Journal:  Lipids Health Dis       Date:  2014-12-04       Impact factor: 3.876

7.  Application of a Nanotechnology-Based, Point-of-Care Diagnostic Device in Diabetic Kidney Disease.

Authors:  Vinay Kumar; Suraj Hebbar; Ananthram Bhat; Sachin Panwar; Madhumati Vaishnav; Kavitha Muniraj; Vasanthi Nath; Reshma Banaki Vijay; Sapna Manjunath; Babithadevi Thyagaraj; Chandraprabha Siddalingappa; Muralidharakrishna Chikkamoga Siddaiah; Indranil Dasgupta; Urmila Anandh; Thummala Kamala; S S Srikanta; P R Krishnaswamy; Navakanta Bhat
Journal:  Kidney Int Rep       Date:  2018-06-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.